Sign in

CIK 0001515673

  • Large accelerated filer

Ultragenyx Pharmaceutical Inc.

Sign in to watch
Ticker
RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272546083
Phone
+1 415-483-8800
Business address
60 LEVERONI COURT, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$127,561
in 3 filings, $17K under 10b5-1 plans

Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-04-16 Harris Erik EVP & Chief Commercial Officer Grant or award +28,895 118,410
2026-04-16 Harris Erik EVP & Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +49,960 49,960
2026-03-02 Harris Erik EVP & Chief Commercial Officer Sale −10,539 $22.80 $240K 89,515
2026-03-01 Harris Erik EVP & Chief Commercial Officer Grant or award +11,643 99,498
2025-03-03 Harris Erik EVP & Chief Commercial Officer Sale −15,103 $42.10 $636K 87,855
2025-03-01 Harris Erik EVP & Chief Commercial Officer Grant or award +16,813 83,976
2025-03-01 Harris Erik EVP & Chief Commercial Officer Grant or award +18,443 102,419
2025-03-01 Harris Erik EVP & Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +30,246 30,246
2024-03-01 Harris Erik EVP & Chief Commercial Officer Grant or award +19,400 70,681
2024-03-01 Harris Erik EVP & Chief Commercial Officer Grant or award +957 71,638
2024-03-01 Harris Erik EVP & Chief Commercial Officer Sale −4,768 $53.76 $256K 67,163
2024-03-01 Harris Erik EVP & Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +34,200 34,200
2023-09-05 Harris Erik EVP & Chief Commercial Officer Sale −6,000 $37.96 $228K 51,281
2023-06-19 Harris Erik EVP & Chief Commercial Officer Sale −305 $48.20 $15K 57,281
2023-03-01 Harris Erik EVP & Chief Commercial Officer Grant or award +2,663 38,823
2023-03-01 Harris Erik EVP & Chief Commercial Officer Grant or award +22,000 60,823
2023-03-01 Harris Erik EVP & Chief Commercial Officer Sale −3,664 $45.25 $166K 57,344
2023-03-01 Harris Erik EVP & Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +39,400 39,400
2022-06-19 Harris Erik EVP & Chief Commercial Officer Sale −295 $54.78 $16K 36,160
2022-03-01 Harris Erik EVP & Chief Commercial Officer Sale −2,713 $66.62 $181K 22,317

Page 1 of 3 · 48 trades